Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19

In December 2019, a novel coronavirus pneumonia (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suddenly broke out in China and rapidly spread all over the world. Recently, a cell surface protein, known as angiotensin-converting enzyme II (ACE2), has been identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiuhong, Zhang, Yan, Qiao, Weizhen, Zhang, Ji, Qi, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328558/
https://www.ncbi.nlm.nih.gov/pubmed/32645632
http://dx.doi.org/10.1016/j.intimp.2020.106749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328558/
https://www.ncbi.nlm.nih.gov/pubmed/32645632
http://dx.doi.org/10.1016/j.intimp.2020.106749

Ejemplares similares